| 2007 |
CEP68 localizes to fibres emanating from the proximal ends of centrioles during interphase and dissociates from centrosomes during mitosis. Knockdown of CEP68 causes centrosome splitting, establishing a required role in centrosome cohesion. CEP68 and rootletin depend on each other and on C-Nap1 for centriole association, and CEP68 is readily recruited to ectopic rootletin fibres, indicating it cooperates with rootletin and C-Nap1 in maintaining the intercentrosomal linker. |
siRNA knockdown, immunofluorescence localization, overexpression/ectopic fibre recruitment assays |
Journal of cell science |
High |
18042621
|
| 2014 |
CEP68 is degraded in prometaphase via the SCF(βTrCP) ubiquitin ligase. PLK1 phosphorylates CEP68 on Ser332, creating a phosphodegron recognized by βTrCP. CEP68 forms a complex with Cep215 (Cdk5Rap2) and pericentrin (PCNT); its degradation allows removal of Cep215 from the peripheral PCM, which is required to prevent aberrant centriole separation following disengagement. |
Mass spectrometry (interactome), co-immunoprecipitation, in vitro ubiquitylation assay, phosphorylation site mutagenesis, siRNA knockdown with centrosome phenotype readout |
Nature cell biology |
High |
25503564
|
| 2014 |
Centlein (CNTLN) directly interacts with both C-Nap1 and CEP68, acting as a molecular bridge between them at the proximal ends of centrioles. Depletion of centlein impairs recruitment of CEP68 to centrosomes and causes centrosome splitting. Both centlein and CEP68 are phosphorylation substrates of Nek2A. |
Co-immunoprecipitation, yeast two-hybrid, siRNA knockdown, immunofluorescence, in vitro kinase assay |
Journal of cell science |
High |
24554434
|
| 2018 |
STED super-resolution microscopy revealed that the centrosome linker is organized as a periodic rootletin/CEP68 network. C-Nap1 forms a ring at each centriole that anchors rootletin rings and rootletin/CEP68 fibres. Rootletin binds CEP68 via its C-terminal spectrin repeat-containing region in 75-nm intervals. CEP68 modulates the branching of rootletin filaments off centrioles and regulates the thickness of rootletin fibres. |
STED nanoscopy, structured illumination microscopy, siRNA knockdown, domain-mapping co-immunoprecipitation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29463719
|
| 2015 |
The C-terminal 300–400 amino acids of CEP68 are necessary for its localization to interphase centrosomes, while the C-terminal 400–500 aa region regulates its dissociation from centrosomes at mitotic onset. Nek2 phosphorylates CEP68 in vivo and this phosphorylation promotes CEP68 degradation in mitosis. The SCF(βTrCP) complex targets CEP68 for proteasomal destruction at mitosis. |
Truncation/deletion constructs with live-cell localization, in vivo phosphorylation assay, co-immunoprecipitation with βTrCP |
European journal of cell biology |
Medium |
25704143
|
| 2017 |
Rootletin prevents CEP68 from VHL-mediated proteasomal degradation. In the absence of rootletin, the VHL E3 ligase complex ubiquitinates CEP68 both in vitro and in vivo, leading to its proteasomal degradation and centrosome splitting. Co-silencing of rootletin and VHL, or expression of a stable CEP68 mutant that lacks VHL-β-domain binding or polyubiquitylation sites, rescues centrosome splitting caused by rootletin depletion. |
In vitro ubiquitylation assay, co-immunoprecipitation, siRNA double knockdown (epistasis), stable CEP68 mutant rescue experiments |
Biochimica et biophysica acta. Molecular cell research |
High |
28089774
|
| 2017 |
MCM7 directly binds CEP68 in vitro and forms a complex with CEP68 and VHL in vivo. MCM7 overexpression facilitates the CEP68–VHL interaction, enhancing CEP68 ubiquitination and proteasomal degradation, resulting in centrosome splitting. Depletion of MCM7 weakens the CEP68–VHL interaction. |
In vitro pull-down, co-immunoprecipitation, overexpression and knockdown with centrosome splitting readout, ubiquitination assay |
Biochemical and biophysical research communications |
Medium |
28578000
|
| 2007 |
CEP68 (KIAA0582) is a novel tyrosine-phosphorylation target of EGF receptor signaling in human cancer cells. EGF-induced tyrosine phosphorylation of CEP68 is inhibited by Iressa (gefitinib, an EGFR inhibitor), indicating EGFR kinase activity is required for this modification. |
cICAT-based LC-MS/MS phosphoproteomics, immunoprecipitation/immunoblot validation with EGFR inhibitor treatment |
Proteomics |
Medium |
17570516
|